Abstract

McCune-Albright Syndrome (MAS) is a rare and complex disorder that primarily affects the bones, skin, and endocrine system. It is characterized by a mosaic pattern of somatic mutations in the GNAS gene, leading to constitutive activation of adenylate cyclase and excessive production of cyclic AMP (cAMP). This dysregulated cAMP signaling pathway results in a wide spectrum of clinical manifestations, including polyostotic fibrous dysplasia, café-au-lait skin pigmentation, and various endocrinopathies such as precocious puberty, hyperthyroidism, and hypercortisolism. This comprehensive review aims to provide an in-depth understanding of the pathophysiological mechanisms underlying MAS, a detailed exploration of the diverse clinical features, and a discussion of the current and emerging therapeutic strategies for managing this rare disorder. The article synthesizes research findings, clinical experiences, and genetic insights to shed light on the challenges faced by healthcare providers in diagnosing and treating patients with MAS.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.